Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Clinical trial NCT06422767 · COMPLETED
Trial details
- NCT number
- NCT06422767
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-18
- Primary completion
- 2025-04-28
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.